Search results

This program explores the mechanism and outcome of the interaction of radiation on biological systems in order to improve our understanding of the impact of radiation on the brain, optimise radiotherapy and develop mitigation strategies for space travellers.

The ANSTO Innovation Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

To contact ANSTO you can submit an enquiry or call one of our locations.

ANSTO is home to over AUD$1.3B state of the art instruments and science technology. To access ANSTO’s world-leading and highly specialised facilities and capabilities, please contact our Industry Engagement team. This way we can co-ordinate your enquiry and provide advice on your application.

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Soft x-rays are generally understood to be x-rays in the energy range 100-3,000 eV. They have insufficient energy to penetrate the beryllium window of a hard x-ray beamline but have energies higher than that of extreme ultraviolet light.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

ANSTO provides a summary of water usage and discharge for FY2022 - FY2023

Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.